CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Learn about essential user friendly features to look for in crypto exchanges. Optimize your trading experience with these insights.
19,580 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Federal data show a sharp decline in ACA enrollment as subsidies expired, with about 3 million fewer people insured i...
NASA gears up a bold robotic rescue to preserve the aging Swift Observatory, a move that could influence space-tech i...
A cautionary look at a high-profile case where fake utility customers kept services active for years, costing utiliti...
Micron Technology faces a pivotal moment as AI memory demand accelerates. Analysts weigh a potential multi-year upcyc...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
In 2025, the United States produced a surge of new millionaires, averaging roughly 1,200 per day. The trend lifted th...
Cerebras signals an upcoming IPO as it presses to outpace Nvidia and rival AI-chip startups in the fast-moving genera...
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
A major enforcement push in Louisiana led to 21 new arrests in a Medicaid fraud crackdown. This article explains what...
If you’re itching to buy your first rental but dread the 20% down barrier, you’re not alone. This guide shares three ...
Three major covered-call ETFs compete for monthly income and equity exposure, but their upside and risk profiles dive...